Infusion Drug Delivery Resources
-
Solubility With Lipid-Based Technologies For Oral & Injectable Formulations
11/7/2022
Innovative approaches in developing formulations can help to improve a drug's safety and efficacy. Explore the decision for selecting the best-suited technology for formulating a complex molecule.
-
Snapshot Of The Parenteral Drug Delivery Market
6/17/2022
Growth in the development of parenteral drugs is driving demand for advanced drug delivery devices such as prefilled syringes, autoinjectors, and pen-injectors, growing segments in fill-finish manufacturing.
-
Delivering The Promise Of Gene Therapy
1/22/2024
Gene therapies rely on efficient, precise methods of delivering genetic material. Examine how combining polymeric nanoparticles with CRISPR therapies is increasing the potential for improved treatment.
-
Innovative Formulation Technologies By 505(b)(2) Regulatory Pathway
1/24/2022
Revitalization of older marketed drugs using innovative drug delivery technologies can provide new marketing exclusivity and patent protection, offering an effective tool for product life cycle management.
-
Switching From Vials To PFS And Intravenous To Subcutaneous Formulations
7/25/2023
Learn about formulation development challenges for prefilled syringes as well as considerations for reducing the time it takes to launch safer, more convenient, and cost-effective products for the patient.
-
Is Your Combination Product Drug-Led Or Device-Led?
11/30/2022
The $118 billion combination-product market is projected to increase at a CAGR of 8.8%. This article answers the question: “Is this actually a combination product? What do we need to do if it is?”
-
Considerations In Formulation Development Of Injectable Solutions
2/8/2022
Injectable solutions offer an alternative to oral dosage form due to fast onset, reproducible PK/efficacy profile, high bioavailability, and suitability of administration under hospital setting.
-
Formulation Research Strategy For Discovery- Stage New Drug Candidates
1/24/2022
Early stage formulation studies, which should support the emerging target product profile, will often yield important experimental results to aid subsequent development of clinically relevant dosage forms.